Evaluating the Efficacy of Combined Intravaginal Estriol Therapy and Kegel Exercises in Managing Menopausal Atrophic Vulvovaginitis
- PMID: 39851803
- PMCID: PMC11763434
- DOI: 10.3390/clinpract15010020
Evaluating the Efficacy of Combined Intravaginal Estriol Therapy and Kegel Exercises in Managing Menopausal Atrophic Vulvovaginitis
Abstract
Background: This is a prospective study. Atrophic vulvovaginitis (VVA), a prevalent condition resulting from estrogen deficiency after the menopause, is characterized by symptoms such as vaginal dryness, itching, burning, dyspareunia, and urinary discomfort. Standard treatment involves systemic estrogen replacement therapy (HRT) and localized estrogen treatments, such as estriol. However, many women with moderate-to-severe VVA may not fully benefit from estrogen therapy alone. Non-hormonal adjunctive treatments, such as pelvic floor exercises (e.g., Kegel exercises), are being explored to enhance clinical outcomes. Objectives: This study investigates the combined effect of local estriol therapy and Kegel exercises in improving VVA symptoms in postmenopausal women. Methods: Fifty postmenopausal women diagnosed with VVA were enrolled and divided into three severity groups: mild, moderate, and severe. All participants received estriol therapy (0.5 mg vaginal tablets daily for 10 days each month) for the first three months. Following this, Kegel exercises were introduced for an additional three-month period, alongside continued estriol therapy. Symptom improvement was evaluated after six months, with outcomes categorized as complete remission, partial remission, or no remission. Results: Significant improvements in symptom remission were observed, particularly in the moderate and severe groups. In the mild VVA group, 81.82% achieved complete remission with combined therapy compared to 68.18% with estriol alone. In the severe group, complete remission was observed in 40% of patients receiving combined therapy compared to 20% with estriol therapy alone. These findings suggest that Kegel exercises enhance the effectiveness of estriol by improving local blood circulation, which facilitates better estrogen absorption and distribution. Conclusions: The addition of Kegel exercises to local estriol therapy significantly improves symptom remission rates, especially in moderate and severe VVA cases. This approach offers a promising strategy for managing postmenopausal VVA, particularly in cases that do not fully respond to estrogen therapy alone.
Keywords: Kegel exercises; atrophic vulvovaginitis; estriol therapy; estrogen deficiency; menopause; pelvic floor exercises; postmenopausal symptoms; vulvovaginal atrophy.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.J Sex Med. 2022 May;19(5):761-770. doi: 10.1016/j.jsxm.2022.02.027. Epub 2022 Mar 31. J Sex Med. 2022. PMID: 35370104
-
Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.Gynecol Endocrinol. 2020 Jun;36(6):535-539. doi: 10.1080/09513590.2019.1702016. Epub 2019 Dec 17. Gynecol Endocrinol. 2020. PMID: 31847628 Clinical Trial.
-
Comparison of the effect of noninvasive radiofrequency with vaginal estrogen and vaginal moisturizer in the treatment of vulvovaginal atrophy in postmenopausal women: a randomized clinical trial.Menopause. 2024 Apr 1;31(4):288-302. doi: 10.1097/GME.0000000000002326. Epub 2024 Feb 26. Menopause. 2024. PMID: 38412393 Clinical Trial.
-
Current treatment options for postmenopausal vaginal atrophy.Int J Womens Health. 2018 Jul 31;10:387-395. doi: 10.2147/IJWH.S158913. eCollection 2018. Int J Womens Health. 2018. PMID: 30104904 Free PMC article. Review.
-
Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease.Gynecol Endocrinol. 2021 Aug;37(8):746-752. doi: 10.1080/09513590.2021.1943346. Epub 2021 Jun 25. Gynecol Endocrinol. 2021. PMID: 34169794 Review.
Cited by
-
Placenta Praevia with Abnormal Adhesion-A Retrospective Study.Clin Pract. 2025 Jan 23;15(2):23. doi: 10.3390/clinpract15020023. Clin Pract. 2025. PMID: 39996693 Free PMC article.
References
-
- Portman D.J., Gass M.L. Vulvovaginal Atrophy Terminology Consensus Conference Panel. Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21:1063–1068. doi: 10.1097/GME.0000000000000329. - DOI - PubMed
-
- Nappi R.E., Palomba S. Vaginal Atrophy and Sexuality in Menopause: An Overview of the Pathophysiology, Clinical Management, and Therapeutic Approaches. Climacteric. 2010;13:238–246. - PubMed
-
- Nappi R.E., Albani L. Local Estrogens for Vulvovaginal Atrophy: Efficacy and Safety. Climacteric. 2009;12:424–432.
-
- Miller J.S., Keast E.S. The Role of Estrogen in the Pathophysiology of Vaginal Atrophy. Menopause. 2008;15:751–757.
LinkOut - more resources
Full Text Sources